ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3024

Fcγriiia Mediated Signal Cause Epigenetic Changes in Human Naive CD4+ T-Cells

Ye Bi1, Chen Chen2, Terry Moore3 and Anil K. Chauhan4, 1Internal Medicine, Saint Louis University, St. Louis, MO, 2Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Division of Rheumatology and Pediatric Rheumatology, Saint Louis University School of Medicine, St Louis, MO, 4Internal Medicine-Rheumatology, Saint Louis University, St Louis, MO

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Epigenetics, Fc receptors, interferons and toll-like receptors, T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: T cell Biology and Targets in Autoimmune Disease Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Signals that trigger epigenetic changes in CD4+ T-cells are unknown. To examine a role for FcγRIIIa mediated co-signal in causing epigenetic changes in human CD4+ T-cells. GWAS studies have shown hypomethylation of IFN promoter region in CD4+ T-cells. During IFN signaling multiple genome sites are hypomethylated. Procainamide and hydrazine, which inhibit DNA (cytosine-5)-methyltransferase 1 (DNMT1), predispose individuals to drug-induced systemic lupus erythematosus (SLE). We examined whether immune complexes (ICs) by ligating FcγRIIIa on CD4+ T-cells cause epigenetic changes. 

Methods:

We activated peripheral human naïve CD4+ T-cells using plate bound anti-CD3+anti-CD28 and anti-CD3+ICs+C5b-9. Thereafter, we cultured these cells in TH17 polarizing conditions. On day nine, we harvested the cells and prepared cDNA. PCR array was performed using chromatin modification array (n=6) (Applied Biosystems) and Human Epigenetic Chromatin Modification Enzyme RT2Profiler PCR array (n=5) (SA Biosciences). We compared the relative change in DNA and histone modifying enzyme genes from ICs+C5b-9 co-stimulation over CD28 co-stimulation. Epigenetic marks were examined by ChiP assay.

Results:

In six donors analyzed by AB array, hierarchical cluster analysis showed a strong correlation among DNMT1, RBBP7, CHD4, and MBD2, which are part of deacetylases complex. All enzymes of this complex were repressed by ICs ligation to CD4+ T-cells. A dramatic decrease (4.5 fold) was observed in co-activator associated arginine methyl transferase and nuclear receptor co-activator (NCOA6) (7.14 fold), which remodels chromatin with HAT1. A 7.37-fold increase was observed in activating transcription factor 2 (ATF2), which acetylates H2B and H4 histones during DNA damage response, from ICs ligation of FcγRIIIa on CD4+ T-cells compared to CD28 co-stimulation. ATF2/c-Jun regulated IFN-β gene and IFN-γ production. K(lysine) acetyl transferase 6A (KAT6A) was increased 6-fold, which acetylate H3 and H4 histones. KAT6A is a transcriptional co-activator of Runx1 and Runx2. Both T-bet and Runx generate pathogenic IFN-γ producing TH17 cells. In addition, a 6.16-fold increase in SET domain containing lysine methyltransferases (SETD)-7, a transcription activator that generates H3K4 mark was observed. Also other SET domain proteins SET4, SET8 that generate H4K2me1 mark and SET1 that generates H3K9 mark were upregulated. Relative increase in the expression of ATF2, KAT6A, and SEDT7 was seen in both arrays. 

Conclusion:

Epigenetic modifications contribute to multistep differentiation and plasticity of in vitro and in vivo-derived helper T-cells. Our results show that signal via FcγRIIIa in CD4+ T-cells modulates both histones and DNA modifying enzymes. Ligation of FcγRIIIa by ICs lead to the development of IFN-γhigh subset. ATF2 and c-Jun bind to -53 CpG in the IFN-γ promoter in TH1 and not in TH2 cells. Persistent signaling from IC ligation to FcγRIIIa by up-regulating ATF2 will continue to generate IFN-γ producing cells.


Disclosure: Y. Bi, None; C. Chen, None; T. Moore, None; A. K. Chauhan, None.

To cite this abstract in AMA style:

Bi Y, Chen C, Moore T, Chauhan AK. Fcγriiia Mediated Signal Cause Epigenetic Changes in Human Naive CD4+ T-Cells [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/fci%c2%b3riiia-mediated-signal-cause-epigenetic-changes-in-human-naive-cd4-t-cells/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fci%c2%b3riiia-mediated-signal-cause-epigenetic-changes-in-human-naive-cd4-t-cells/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology